Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Otte

Showing results (201-210 of 209) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 209 results.
Journal of Affective Disorders|February 15, 2024
Depression and fatigue six months post-COVID-19 disease are associated with overlapping symptom constellations: A prospective, multi-center, population-based cohort studyMartin Weiß, Julian Gutzeit, Katharina S Appel, et al.
BMJ Open|December 2, 2020
Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trialChristian Otte, Woo Ri Chae, Jan Nowacki, et al.
Depression and Anxiety|December 5, 2025
Clinical and Treatment Characteristics of 3795 Adults Consecutively Hospitalized for Major Depressive Disorder in the OASIS-D StudyViktor B Nöhles, Felix Bermpohl, Nikola Schoofs, et al.
JAMA Psychiatry|June 4, 2025
Simvastatin as Add-On Treatment to Escitalopram in Patients With Major Depression and Obesity: A Randomized Clinical TrialChristian Otte, Woo Ri Chae, Deniz Yildirim Dogan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 19, 2026
Psychomotor slowing as a predictor of treatment outcomes in major depressive disorder with acute suicidality: Insights from the OASIS-D studyStefan Fritze, Iris Reinhard, Viktor B Nöhles, et al.
Brain, Behavior, & Immunity - Health|June 8, 2026
An externally validated machine learning algorithm for predicting mental and physical health outcomes three months post-hospitalization for severe viral infection with SARS-CoV-2Katharina Schultebraucks, Sapir Gershov, Felix Fischer, et al.
BMJ Neurology Open|July 6, 2026
Stroke and its consequences: protocol and pilot data of the observational Berlin Long-term Observation of Vascular Events (BeLOVE) stroke stratumChristian H Nolte, Joachim E Weber, Michael Ahmadi, et al.
Molecular Psychiatry|December 15, 2021
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trialsLuca Sforzini, Courtney Worrell, Melisa Kose, et al.
Infection|July 11, 2023
Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)Fridolin Steinbeis, Charlotte Thibeault, Sarah Steinbrecher, et al.
Pageof 21

Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
Journal of Affective Disorders|February 15, 2024
Depression and fatigue six months post-COVID-19 disease are associated with overlapping symptom constellations: A prospective, multi-center, population-based cohort studyMartin Weiß, Julian Gutzeit, Katharina S Appel, et al.
BMJ Open|December 2, 2020
Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trialChristian Otte, Woo Ri Chae, Jan Nowacki, et al.
Depression and Anxiety|December 5, 2025
Clinical and Treatment Characteristics of 3795 Adults Consecutively Hospitalized for Major Depressive Disorder in the OASIS-D StudyViktor B Nöhles, Felix Bermpohl, Nikola Schoofs, et al.
JAMA Psychiatry|June 4, 2025
Simvastatin as Add-On Treatment to Escitalopram in Patients With Major Depression and Obesity: A Randomized Clinical TrialChristian Otte, Woo Ri Chae, Deniz Yildirim Dogan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 19, 2026
Psychomotor slowing as a predictor of treatment outcomes in major depressive disorder with acute suicidality: Insights from the OASIS-D studyStefan Fritze, Iris Reinhard, Viktor B Nöhles, et al.
Brain, Behavior, & Immunity - Health|June 8, 2026
An externally validated machine learning algorithm for predicting mental and physical health outcomes three months post-hospitalization for severe viral infection with SARS-CoV-2Katharina Schultebraucks, Sapir Gershov, Felix Fischer, et al.
BMJ Neurology Open|July 6, 2026
Stroke and its consequences: protocol and pilot data of the observational Berlin Long-term Observation of Vascular Events (BeLOVE) stroke stratumChristian H Nolte, Joachim E Weber, Michael Ahmadi, et al.
Molecular Psychiatry|December 15, 2021
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trialsLuca Sforzini, Courtney Worrell, Melisa Kose, et al.
Infection|July 11, 2023
Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)Fridolin Steinbeis, Charlotte Thibeault, Sarah Steinbrecher, et al.
Pageof 21